Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001213900-26-037438
Filing Date
2026-03-31
Accepted
2026-03-31 16:08:42
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0283925-424b7_ostherap.htm 424B7 494143
2 FILING FEE TABLE ea028392501ex-fee.htm   iXBRL EX-FILING FEES 14501
3 GRAPHIC ea028392501_img1.jpg GRAPHIC 17941
4 GRAPHIC ea028392501_img2.jpg GRAPHIC 130660
5 GRAPHIC ea028392501_img3.jpg GRAPHIC 48961
  Complete submission text file 0001213900-26-037438.txt   907020

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ea028392501ex-fee_htm.xml XML 5532
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-289443 | Film No.: 26821762
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)